Who invested in Avicenna.ai

One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Funding summaryUpdated 26 Oct 2026

$7.5Mraised across 1 round since 2023, from 1 source

Latest round: Series A, $7.5MFeb 2023
Investors: 1

See who backed them

The rounds

Feb 2023
Series A$7.5M
- Innovacom
Source recorded

Founders and team

From Avicenna.ai's own website: 2 founders, 14 on the team.

Cyril Di GrandiCo-founder and Chief Executive Officer

Peter ChangCo-founder and Chief Medical Officer

Martijn JonkersVP Sales EMEA
Angela AyobiClinical Studies Manager
Christophe AvareResearch and Development Manager
Cécile MadarasRegulatory and Clinical Affairs Engineer
Isaure De NobletProject Manager
Mar RocaResearch and Developement Engineer
Marc-Adrien HostinResearch & Development Engineer
Michael GirardotSenior R&D Engineer
Olivier FuseriBusiness Development Manager
Paolo DupontTechnical Manager
Sarah QuenetProduct Manager
Stéphane BergerRegulatory and Quality Manager
Stéphanie BellaviaMarketing and Communication Manager
Yasmina ChaibiClinical Affaires & Validation Manager

Everyone who backed them

InnovacomVC firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

These 2 firms list Avicenna.ai as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.